BRCA2 and ovarian cancer: Preliminary in vitro data from our lab supports this hypothesis, as overexpression of MAGEC3 results in a reduction in BRCA2 protein level in both fibrosarcoma (HT1080) and ovarian cancer (SKOV3) cell lines [56].